Tobacco News and Research RSS Feed - Tobacco News and Research

Alcohol advertising pre-disposes young people to have favorable attitudes toward drinking

In order to avoid exposing vulnerable groups such as children and young adults to alcohol advertising, industry groups have developed their own self-regulation guidelines. However, these guidelines have been criticized for possible conflict of interest, lack of objectivity, and unresponsiveness to complaints about violations. [More]
FDA seeks injunction in court against New York City Fish

FDA seeks injunction in court against New York City Fish

The U.S. Department of Justice, on behalf of the U.S. Food and Drug Administration, is seeking a preliminary injunction in the U.S. District Court for the Eastern District of New York against New York City Fish, Inc., and several key employees for manufacturing and distributing ready-to-eat fish products under insanitary conditions causing them to become adulterated. [More]
Study reveals that heart disease risk factor management differs among outpatient practices

Study reveals that heart disease risk factor management differs among outpatient practices

Control of heart disease risk factors varies widely among outpatient practices, according to a study presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2013. [More]
Researchers evaluate distribution of Spanish smoking relapse prevention booklet series

Researchers evaluate distribution of Spanish smoking relapse prevention booklet series

Researchers from Moffitt Cancer Center and the University of South Florida have evaluated how Florida health care and social service agencies distribute "Libres para Siempre" ("Forever Free-"), a Spanish smoking relapse prevention booklet series. [More]
Simponi injection gets FDA approval to treat adults with ulcerative colitis

Simponi injection gets FDA approval to treat adults with ulcerative colitis

The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis. [More]

Prostate cancer drug Xofigo gets FDA approval

The U.S. Food and Drug Administration today approved Xofigo (radium Ra 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs. [More]

Microclinic International to promote healthier living in the Cumberland Valley Region

Microclinic International was awarded a major CDC grant to promote healthier living and combat chronic disease in the Cumberland Valley Region in Appalachian Kentucky. [More]

Survey: Prevalence of smokeless tobacco use among youths did not change between 2000 and 2011

Tobacco use remains the leading preventable cause of death and disease in the United States. Declines in smoking among youths were observed from the late 1990s. "However, limited information exists on trends in smokeless tobacco use among U.S. youths," writes Israel T. Agaku, D.M.D., M.P.H., of the Harvard School of Public Health, Boston, and colleagues. [More]
Roundup: Ore. Health Co-Ops to compete with big insurers; Texas lawmakers find money for mental health, women's care

Roundup: Ore. Health Co-Ops to compete with big insurers; Texas lawmakers find money for mental health, women's care

Armed with hefty federal loans, two startup health insurers are jumping into a crowded and confusing Oregon market just as the biggest changes to U.S. health care in generations roll out this fall. [More]

New nimodipine oral solution receives FDA approval for subarachnoid hemorrhage treatment

On May 10, the U.S. Food and Drug Administration approved Nymalize, a new nimodipine oral solution, to treat patients experiencing symptoms resulting from ruptured blood vessels in the brain (subarachnoid hemorrhage). [More]
ALKBH7 protein plays key role in controlling programmed necrosis pathway

ALKBH7 protein plays key role in controlling programmed necrosis pathway

When cells suffer too much DNA damage, they are usually forced to undergo programmed cell death, or apoptosis. However, cancer cells often ignore these signals, flourishing even after chemotherapy drugs have ravaged their DNA. [More]

CEO Roundtable on Cancer accredits Baptist Memorial Health Care with CEO Cancer Gold Standard

Baptist Memorial Health Care is leading by example when it comes to promoting workplace wellness and encouraging healthier behavior. The CEO Roundtable on Cancer recently accredited Baptist Memorial Health Care with the CEO Cancer Gold Standard. [More]
Research may help scientists learn anti-aging secrets of sacred lotus

Research may help scientists learn anti-aging secrets of sacred lotus

A team of 70 scientists from the U.S., China, Australia and Japan today reports having sequenced and annotated the genome of the "sacred lotus," which is believed to have a powerful genetic system that repairs genetic defects, and may hold secrets about aging successfully. [More]
Food Defense Plan Builder: FDA's new tool to help food industry craft defense measures

Food Defense Plan Builder: FDA's new tool to help food industry craft defense measures

The U.S. Food and Drug Administration has released a new tool to help bolster the food industry's defense measures against an act of intentional food contamination. [More]

Juice products from Juices Incorporated have potential health risk, FDA warns

The U.S. Food and Drug Administration is warning consumers not to consume any juice products or other beverages from Juices Incorporated (aka Juices International and Juices Enterprises) of Brooklyn, N.Y. [More]
Breo Ellipta gets FDA approval for treatment of airflow obstruction in patients with COPD

Breo Ellipta gets FDA approval for treatment of airflow obstruction in patients with COPD

The U.S. Food and Drug Administration today approved Breo Ellipta (fluticasone furoate and vilanterol inhalation powder) for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and/or emphysema. [More]
Study shows chronic exposure to cadmium may cause liver disease

Study shows chronic exposure to cadmium may cause liver disease

People with higher levels of cadmium in their urine — evidence of chronic exposure to the heavy metal found in industrial emissions and tobacco smoke — appear to be nearly 3.5 times more likely to die of liver disease than those with lower levels, according to a study by Johns Hopkins scientists. [More]
Nicotine in peppers and tomatoes may provide protective effect against Parkinson's disease

Nicotine in peppers and tomatoes may provide protective effect against Parkinson's disease

New research reveals that Solanaceae-a flowering plant family with some species producing foods that are edible sources of nicotine-may provide a protective effect against Parkinson's disease. The study appearing today in Annals of Neurology, a journal of the American Neurological Association and Child Neurology Society, suggests that eating foods that contain even a small amount of nicotine, such as peppers and tomatoes, may reduce risk of developing Parkinson's. [More]

CEO Roundtable on Cancer recognizes efforts of Methodist Le Bonheur Healthcare

The CEO Roundtable on Cancer recently accredited Methodist Le Bonheur Healthcare with the CEO Cancer Gold Standard, recognizing the health care system's efforts to reduce the risk of cancer for their employees and covered family members by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment. [More]

Products from The Compounding Shop lack sterility assurance, FDA warns

The U.S. Food and Drug Administration is alerting health care providers, hospital supply managers, and pharmacists that the FDA's preliminary findings of practices at The Compounding Shop of St. Petersburg, Fla., raise concerns about a lack of sterility assurance for sterile drugs produced at and distributed from this site. [More]